| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029957 8-beta-substituted estratrienes as selectively active estrogens |
| 01/29/2009 | US20090029955 Pyridothienopyrimidine Derivatives |
| 01/29/2009 | US20090028944 Pharmaceutical compositions comprising mesalamine |
| 01/29/2009 | US20090028941 Pulsatile gastric retentive dosage forms |
| 01/29/2009 | US20090028940 Pharmaceutical compositions of rifaximin |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028828 Rotavirus Vaccine Inducing Heterotypic Cross Protection |
| 01/29/2009 | US20090028824 Systems and methods for delivering drugs |
| 01/29/2009 | DE102007034682A1 Injection device for injection into biological tissue with injection syringe into organism, has actuating device with actuating element that forms abutment for piston device of injection syringe on guide device |
| 01/29/2009 | CA2694443A1 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein |
| 01/28/2009 | EP2018377A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018375A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018158A1 New form of administration of racecadotril |
| 01/28/2009 | EP2018151A1 Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1391505B1 Stem cells and method of separating the same |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356176A Therapeutic or prophylactic agent for functional bowel disorder |
| 01/28/2009 | CN101355943A Therapeutic agent for nausea and/or vomiting |
| 01/28/2009 | CN101355942A Solid dispersions of opioid antagonists |
| 01/28/2009 | CN101352574A Target polypeptide-gold/silicon dioxide nano complex particle and synthesis thereof |
| 01/28/2009 | CN101352566A Chinese medicine preparation for harmonizing nutrient and defence and preparation method thereof |
| 01/28/2009 | CN101352558A Quality control method of granular formulation for treating gastricism without aversion to cold |
| 01/28/2009 | CN101352554A Chinese medicine preparation for treating gastropathy |
| 01/28/2009 | CN101352553A Fragrant fruit digestion promotion tablet and production method |
| 01/28/2009 | CN101352552A Capsules for promoting children's intelligence, growth and development |
| 01/28/2009 | CN101352551A Medicament for treating liver disease |
| 01/28/2009 | CN101352550A New use of compound medicament composition |
| 01/28/2009 | CN101352547A Oral medicament for treating cholecystitis |
| 01/28/2009 | CN101352514A Chinese medicinal composition for treating myasthenia gravis and preparation method thereof |
| 01/28/2009 | CN101352511A Medicated health-caring wine |
| 01/28/2009 | CN101352496A Chinese medicine for treating hepatitis |
| 01/28/2009 | CN101352493A Chinese medicine with functions for reducing fat and clearing liver and preparation method thereof |
| 01/28/2009 | CN101352488A Medicament composition for damp-heat type icterohepatitis and preparation method thereof |
| 01/28/2009 | CN101352484A Medicament composition for treating acute and chronic hepatitis |
| 01/28/2009 | CN101352479A Medicament for treating gastritis and preparation method thereof |
| 01/28/2009 | CN101352465A Method for preparing ginseng health product medicinal granules |
| 01/28/2009 | CN101352462A Chinese actinidia root triterpenes compounds and extracting method thereof |
| 01/28/2009 | CN101352457A Cordyceps sinensis effervescing agent |
| 01/28/2009 | CN101352455A Method for preparing propolis suspending liquid |
| 01/28/2009 | CN101352439A Composition injection containing tetrandrine and preparation method thereof |
| 01/28/2009 | CN101352429A Use of tiopronin in preparing medicament for treating liver function damage induced by cerebral ischemia, diabetes and obesity |
| 01/28/2009 | CN101352427A Use of shikimic acid in preparing medicament for treating ulcerative colitis |
| 01/28/2009 | CN101352423A Omeprazole sodium lyophilized preparation for injection and preparation method thereof |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455306C Traditional Chinese medicine preparation for treating stomach and intestinal disease and its preparation |
| 01/28/2009 | CN100455302C Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 01/28/2009 | CN100455300C Compound wild kiwi tablet and its preparing method |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455286C Injection of palonosetron and preparation process thereof |
| 01/28/2009 | CN100455282C Process for producing medicine |
| 01/28/2009 | CN100455203C A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal |
| 01/27/2009 | US7482463 Amorphous form of esomeprazole salts |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482321 Extended glucagon-like peptide-1 analogs |
| 01/27/2009 | US7482025 Biomaterial derived from vertebrate liver tissue |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2294586C Homoserine lactones biofilm regulating compounds and their methods of use |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2197319C Lipid analogs for treating viral infections |
| 01/22/2009 | WO2009011413A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | WO2009010987A1 An improved process for the preparation of pure palonosetron hydrochloride |
| 01/22/2009 | WO2009010763A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010555A1 New drugs with anticholestatic activity |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009009951A1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | US20090023814 Compositions and methods having mt1 receptor activity |
| 01/22/2009 | US20090023802 liquid-crystal media used in electro-optical displays; treatment or prophylaxis of diseases or symptoms which can be influenced by inhibition of cannabinoid receptors |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023771 Pharmaceutical composition comprising a proton pump inhibitor and protein component |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023757 Process for preparing bicyclic compounds |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023704 Novel Compounds 737 |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023639 Methods of Treatment |